AMANDA LEWIS joins us from the Federal Trade Commission, where she worked as an attorney in the Bureau of Competition since 2012. While at the FTC, Ms. Lewis served for over two and a half years as a Counsel-Detailee to the Antitrust Subcommittee of the House Judiciary Committee. In this role, Ms. Lewis worked extensively on the House Subcommittee’s Investigation of Competition in Digital Markets, for which Ms. Lewis led the portion of the investigation related to Amazon.

Ms. Lewis was one of the primary authors of the Majority Staff Report and Recommendations and helped draft the bills currently making their way through Congress to rein in Big Tech. In addition, Ms. Lewis took the lead on health care for the Subcommittee, overseeing several hearings related to competition in the healthcare sector and a successful, bipartisan markup of four healthcare antitrust bills, resulting in all four bills being reported out of Committee on a unanimous, bipartisan basis and the enactment of two bills into law, including the CREATES Act and the Competitive Health Insurance Reform Act.

At the FTC, as an attorney in the Mergers IV division, Ms. Lewis worked on the Staples/Office Depot and Sysco/U.S. Foods litigation teams, as well as numerous other merger and conduct investigations.

Prior to the FTC, Ms. Lewis was an associate at Cravath, Swaine & Moore and a law clerk for Judge Lawrence McKenna of the Southern District of New York. She received her B.A. from New York University in 2002 and her J.D. from Columbia Law School in 2008.

Associations & Memberships

• Member, Policy Task Force, COSAL (2022-Present)
• Co-Chair, U.S. Comments and Policy Committee, Section of Antitrust Law, American Bar Association (2022-Present)
• Vice Chair, Health Care and Pharmaceuticals Committee, Section of Antitrust Law, American Bar Association (2017-2022)
• Member, Biden Health Policy Committee, Subcommittee on Cost Containment; voluntary role designated by the Biden for President Campaign (Summer 2020)

In The News

GCR – Big Tech foe to leave Congress
Feb 2023

POLITICO – All Tomorrow’s Monopolies
Sept 2022

Press Release – Amanda Lewis Joins CGL
Sept 2022

Bloomberg – Amazon’s iRobot Deal Seen Facing Tough FTC Antitrust Review
Aug 2022

FTC Watch – People – Amanda Lewis Joins CGL
Jul. 2022

Digital Future Daily, Politico – Transitions highlighting Statement From Subcommittee Chair David Cicilline
Sept. 2021

Protocol.com – A tiny team of House staffers could change the future of Big Tech
Oct. 2020

Publications and Speaking Engagements

• Editor – Judging Big Tech, The Washington Center for Equitable Growth (Dec. 2022)
• The Federalist Society – Biden’s Antitrust Agenda: Mission Creep or Mission Achieved? (Jul. 2022)
• IPLeadership – LeadershIP DMA Virtual Event: EU DMA vs. US Legislative Proposals: Lessons and Path Forward (Jun. 2022)
• ABA Panel – From Investigation to Litigation – Practical Skills for Handling Pharma Matters and Beyond (Jun. 2022)
• ABA Antitrust in Healthcare Virtual Conference – Antitrust Legislation: New Powers for State and Federal Enforcers(Feb. 2021)
• NYIPLA Presidents’ Forum, States Rights: Should States Legislate Intellectual Property in the Pharmaceutical Sector? ( Dec. 2020)
• AAI Pharmaceutical Markets –  Competition Roundtable American Antitrust Institute (Sept. 2019)
• Executive Editor, Health Care Chronicle, Section of Antitrust Law, American Bar Association (2014-2022)